SD-208
SIGMA/S7071 - ≥98% (HPLC), powder
Synonym: 2-
CAS Number: 627536-09-8
Empirical Formula (Hill Notation): C17H10ClFN6
Molecular Weight: 352.75
MDL Number: MFCD11519969
Linear Formula: C17H10ClFN6
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white to tan |
| form | powder |
| InChI | 1S/C17H10ClFN6/c18-10-1-2 |
| InChI key | BERLXWPRSBJFHO-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Fc1ccc(Cl)cc1-c2nc(Nc3ccn |
| solubility | DMSO: >5 mg/mL |
| storage temp. | 2-8°C |
| Application: | SD-208 was used to inhibit the activity of ALK5 kinase in bovine retinal vascular cells.2 |
| Biochem/physiol Actions: | SD-208 is a novel transforming growth factor beta receptor I (TGF-βR I) kinase inhibitor. SD-208 inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. |
| Biochem/physiol Actions: | SD-208 is an inhibitor of TGF β receptor 1 kinase that is reportedly effective against human malignant gliomas. It increases the lytic activity and tumor infiltration by polyclonal natural killer cells, CD8 T cells and macrophages.1 |
| Biochem/physiol Actions: | SD-208 is TGF-βR I kinase inhibitor with IC50 =49 nM based on direct enzymatic assay of TGFRI kinase (ALK5) activity with a specificity of >100-fold against TGFRII and at least 17-fold over members of a panel of related protein kinases including p38a, p38b, p38d, JNK1, EGFR, MAPKAPK2, MKK6, ERK2, PKC, PKA, PKD, CDC2, and CaMKII. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


